ABBV vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

ABBV

44.3
AI Score
VS
ABBV Wins

SYRE

37.7
AI Score

Investment Advisor Scores

ABBV

44score
Recommendation
HOLD

SYRE

38score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric ABBV SYRE Winner
Forward P/E 16.3934 0 Tie
PEG Ratio 0.5421 0 Tie
Revenue Growth 10.2% 0.0% ABBV
Earnings Growth 290.4% -99.7% ABBV
Tradestie Score 44.3/100 37.7/100 ABBV
Profit Margin 9.8% 0.0% ABBV
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY ABBV

Relative Price Performance (Last 90 Days)

ABBV 1M: +7.5% · 3M: +9.9% SYRE 1M: +4.3% · 3M: -9.9%

Current Technical Phase

ABBV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 65

RSI (14): 64.6 · Price: $284.93

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 56.7 · Price: $92.00

Fundamentals Snapshot

Metric ABBV SYRE
Market Cap — —
Forward P/E 17.6 -26.3
Trailing P/E 80.5 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% —
Operating Margin 0.4% 0.0%
EPS 3.54 -1.95
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, ABBV is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.